USNA
Q3 2026 EPS Estimate
$0.43
Aug 4, 2026 · Reports after close
Revenue Estimate
$235M
FY2027E EPS$2.12
FY2028E EPS$2.77

Analyst Sentiment

Wall St. Consensus
Hold
8 analysts·Limited coverage
53
Score
2 Buy (25%)5 Hold (63%)1 Sell (12%)
Rating Breakdown
Strong Buy
00%
Buy
225%
Hold
563%
Sell
113%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$35.00
+48.4%
Consensus
$35.00
+48.4%
Bull
$35.00
+48.4%
12-Month Target Range8 analysts
$35.00$35.00$35.00
Current $23.59Consensus
Current Price
$23.59
Upside to Consensus
$11.41

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+2.17%
EPS+21.84%
FY2028
Rev+6.06%
EPS+30.66%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2027EFY2028E
Revenue Avg$945M$1.00B
Low$945M$1.00B
High$945M$1.00B
EBITDA Avg$119M$127M
Low$119M$127M
High$119M$127M
EBIT Avg$94M$100M
Low$94M$100M
High$94M$100M
Net Income Avg$39M$51M
Low$39M$51M
High$39M$51M
EPS Avg$2.12$2.77
Low$2.12$2.77
High$2.12$2.77
Analysts (Rev / EPS)1 / 11 / 1
Quarterly
MetricQ4 2026Q1 2027Q2 2027Q3 2027Q4 2027Q1 2028
Revenue Avg$225M$235M$259M$252M$240M$252M
Low$225M$235M$259M$252M$240M$252M
High$225M$235M$259M$252M$240M$252M
EBITDA Avg$28M$30M$33M$32M$30M$32M
Low$28M$30M$33M$32M$30M$32M
High$28M$30M$33M$32M$30M$32M
EBIT Avg$22M$24M$26M$25M$24M$25M
Low$22M$24M$26M$25M$24M$25M
High$22M$24M$26M$25M$24M$25M
Net Income Avg$8M$12M$12M$12M$14M$14M
Low$8M$12M$12M$12M$14M$14M
High$8M$12M$12M$12M$14M$14M
EPS Avg$0.43$0.65$0.64$0.65$0.74$0.75
Low$0.43$0.65$0.64$0.65$0.74$0.75
High$0.43$0.65$0.64$0.65$0.74$0.75
Analysts (Rev / EPS)1 / 11 / 11 / 11 / 11 / 11 / 1

Earnings Surprises

Recent Analyst Actions

Oct 23, 2024D.A. Davidson
USANA Health Sciences Inc. (USNA) PT Lowered to $35 at DA Davidson
Target:$35.00
+1.5%from $34.48
Jul 25, 2024D.A. Davidson
Usana price target lowered to $38 from $46 at DA Davidson
Target:$38.00
-11.6%from $42.97
May 7, 2024D.A. Davidson
USANA Health Sciences Inc. (USNA) PT Lowered to $46 at DA Davidson
Target:$46.00
+2.7%from $44.79
Apr 27, 2022D.A. Davidson
DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $76
Target:$76.00
+0.6%from $75.52
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.